An enzyme-labeled antibody diluent for ELISA detection kit and a preparation method thereof
By using enzyme-label antibody diluents containing bovine serum albumin, polyvinylpyrrolidone, FeSO4, thioredoxin and preservatives in the ELISA kit, the problem of inconvenient storage of enzyme-label antibody diluents is solved, and the kit is improved Stability and accuracy achieve the long-term effectiveness of the kit.
Patent Information
- Application Number
- CN202410279565.1
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Filing Date
- 2024-03-12
- Publication Date
- 2024-11-12
- Estimated Expiration
- 2044-03-12
AI Technical Summary
The enzyme-label antibody dilutions in the existing ELISA kit cannot be used for a long time after being stored at low temperature, which affects the stability and accuracy of the kit, and needs to be prepared and used on time, making it inconvenient to use.
A diluent of enzyme-labeled antibody containing 0.1 to 1.0% bovine serum albumin, 0.1 to 1.0% polyvinylpyrrolidone, 1 to 8 mM FeSO4, 0.02 to 0.2% thioredoxin and 0.01 to 0.1% Preservatives, through the synergistic effect of these ingredients, significantly improve the stability of the enzyme-labeled antibody, so that it can be stored at 2 to 8°C, avoiding ready-made use.
It significantly improves the accuracy and stability of the ELISA kit, extends the shelf life of the kit, and makes it more convenient to use. The diluted enzyme-labeled antibody can be stored with the kit to ensure the long-term reliability of the test results.
Smart Images

Figure CN118091113B_ABST
Abstract
Description
Technical Field
[0001] The present application relates to the technical field of enzyme-linked immunosorbent assay, and in particular to an enzyme-labeled antibody diluent for an ELISA detection kit and a preparation method thereof. Background Art
[0002] Enzyme-linked immunosorbent assay (ELISA) is abbreviated as ELISA. The main principle of ELISA antibody detection kit is to adsorb soluble antigens onto solid phase carriers such as polystyrene. The antibodies in the sample react specifically with the antigens adsorbed on the carrier to form antigen-antibody immune complexes. Enzyme-labeled antibodies are added and bound to the solid phase carrier through reaction. Substrates are added for color development reaction, and light absorbance is measured. The purpose of antibody determination is achieved through calculation. Although the ELISA detection method has simple operating steps, there are many influencing factors, among which enzyme-labeled antibody diluent is one of the most important influencing factors. The ELISA method has been widely used in the field of in vitro diagnosis so far, and stability is one of the important factors for users to screen the kit. As we all know, the ELISA kit is composed of multiple components. If the kit is to have good stability during its validity period, the stability of each component is also very important.
[0003] Enzyme-labeled antibodies have two functions in the test: on the one hand, they participate in the immune response and react specifically with the corresponding antigen; on the other hand, they can play the catalytic role of the enzyme and catalyze the chemical reaction of the substrate. The enzyme-labeled antibody here refers to the conjugate of horseradish peroxidase (HRP) and antibody. Selecting the appropriate enzyme-labeled antibody diluent can maintain a stable titer of the enzyme-labeled antibody in the kit and maintain the activity of horseradish peroxidase, ensuring the accuracy and stability of the ELISA kit.
[0004] Enzyme-labeled antibodies are generally stored at -20°C and have a shelf life of up to one year or even longer. However, as components in ELISA kits, it is more convenient to store them at 2-8°C. Previously, people used PBST as a diluent to dilute high-concentration enzyme-labeled antibodies, but the diluted enzyme-labeled antibodies cannot be stored for a long time and must be prepared and used immediately, which is extremely inconvenient to use. Summary of the invention
[0005] In order to solve the deficiencies of the prior art, the present application provides an enzyme-labeled antibody diluent for an ELISA detection kit. The use of the enzyme-labeled antibody diluent can significantly improve the accuracy and stability of the ELISA detection kit.
[0006] To this end, the first aspect of the present application provides an enzyme-labeled antibody diluent for an ELISA detection kit, which comprises the following components in terms of mass concentration (w / v): 0.1-1.0% bovine serum albumin, 0.1-1.0% polyvinyl pyrrolidone, 1-8 mM FeSO4, 0.02-0.2% thioredoxin and 0.01-0.1% preservative.
[0007] In the present application, the bovine serum albumin (BSA) in the enzyme-labeled antibody diluent has the effect of reducing nonspecific reactions, thereby improving the accuracy of the test kit, and BSA can also be used as a protein protectant to protect the enzyme in the enzyme-labeled antibody, reduce enzyme denaturation caused by environmental factors, and improve the stability of the test kit; polyvinyl pyrrolidone and FeSO4 both have the effect of stabilizing antibody protein and horseradish peroxidase, and through the synergistic effect of the two, they can protect the antibody titer and stabilize the activity of the enzyme, thereby improving the stability of the test kit; thioredoxin is an antioxidant, has a good antioxidant effect, can remove free radicals, greatly reduce the probability of antibodies and enzymes being damaged by oxidation, and maintain the stability of the protein. The enzyme-labeled antibody diluent described in the present application significantly improves the stability of the enzyme-labeled antibody through the interaction between the components. The enzyme-labeled antibody diluent can dilute the enzyme-labeled antibody to a working concentration before the product leaves the factory, and can be stored at 2 to 8°C together with the ELISA test kit. It does not need to be prepared and used immediately, which is more convenient to use and effectively extends the shelf life of the test kit.
[0008] In the present application, the enzyme-labeled antibody refers to a conjugate of horseradish peroxidase (HRP) and an antibody.
[0009] In some embodiments, the polyvinyl pyrrolidone is polyvinyl pyrrolidone 40, and the mass concentration of the polyvinyl pyrrolidone is 0.4-0.6%.
[0010] The inventors of the present application have found through research that when the polyvinyl pyrrolidone added to the enzyme-labeled antibody diluent is specifically polyvinyl pyrrolidone 40, and the mass concentration is 0.4-0.6%, especially 0.5%, the stability of the enzyme-labeled antibody diluted with the diluent can be improved.
[0011] In the present application, the FeSO4 added to the enzyme-labeled antibody dilution solution can specifically be FeSO4·7H2O, and the concentration of FeSO4 in the enzyme-labeled antibody dilution solution can be, for example, 1mM, 2mM, 3mM, 4mM, 5mM, 6mM, 7mM or 8mM.
[0012] In some preferred embodiments, the concentration of FeSO4 is 3-5 mM. In some more preferred embodiments, the concentration of FeSO4 is 4 mM.
[0013] The present application helps to further improve the stability of the ELISA detection kit by controlling the concentration of FeSO4 in the enzyme-labeled antibody diluent within the above range.
[0014] In some embodiments, the mass concentration of thioredoxin is 0.08-0.12%. In some preferred embodiments, the mass concentration of thioredoxin is 0.1%.
[0015] The present application helps to further improve the stability of the ELISA detection kit by controlling the mass concentration of thioredoxin in the enzyme-labeled antibody diluent within the above range.
[0016] In some embodiments, the enzyme-labeled antibody diluent further includes lysine, and the mass concentration of the lysine is 1-3%.
[0017] In some preferred embodiments, the mass concentration of lysine is 2%.
[0018] In the present application, lysine is a protein protective agent. By adding lysine to the enzyme-labeled antibody diluent, the enzyme and antibody in the enzyme-labeled antibody can be better protected, thereby protecting the antibody titer and stabilizing the activity of the enzyme, and further improving the stability of the ELISA detection kit.
[0019] In some embodiments, the mass ratio of lysine to bovine serum albumin is (3-5):1.
[0020] In some specific embodiments, the mass ratio of lysine to bovine serum albumin can be 3:1, 4:1 or 5:1, etc. In some preferred embodiments, the mass ratio of lysine to bovine serum albumin is 4:1.
[0021] The present application adjusts the mass ratio of lysine to bovine serum albumin, which helps the two to exert a synergistic effect and enhance the protective effect on the enzyme and antibody in the enzyme-labeled antibody.
[0022] In some embodiments, the enzyme-labeled antibody diluent further includes histidine, and the mass ratio of histidine to thioredoxin is (0.1-1):1.
[0023] In some preferred embodiments, the mass ratio of histidine to thioredoxin is 0.5:1.
[0024] In the present application, histidine is an antioxidant that can effectively reduce the oxidation of enzymes, thereby protecting antibody titer and stabilizing enzyme activity. At the same time, the present application controls the mass ratio of histidine to thioredoxin within the above range, which helps the two to exert a synergistic effect and further improve the stability of the ELISA detection kit.
[0025] In some embodiments, the preservative is selected from at least one of Proclin 150, Proclin 300 and Proclin 950.
[0026] The above-mentioned preservative selected in the present application has a broad-spectrum antibacterial activity, can effectively inhibit the growth of microorganisms such as bacteria and fungi, and will not have a negative impact on the horseradish peroxidase on the enzyme-labeled antibody, will not inhibit the binding of the antigen and the antibody, and has an excellent preservative effect. In some specific embodiments, the preservative can be, for example, Proclin300, and the mass concentration of Proclin300 in the enzyme-labeled antibody diluent can be 0.05%.
[0027] The second aspect of the present application provides a method for preparing the enzyme-labeled antibody diluent as described in the first aspect of the present application, the method comprising: mixing the components in the enzyme-labeled antibody diluent with water, filtering and sterilizing, to obtain the enzyme-labeled antibody diluent.
[0028] In the present application, the amount of each component added when preparing the enzyme-labeled antibody diluent can be calculated by the required volume of the enzyme-labeled antibody diluent and the concentration of the above components; the water used in the preparation process is purified water, and a 0.22 μm water filter membrane can be used for filtration and sterilization.
[0029] The third aspect of the present application is an ELISA detection kit, which includes the enzyme-labeled antibody diluent as described in the first aspect of the present application, or includes an enzyme-labeled antibody solution diluted with the enzyme-labeled antibody diluent as described in the first aspect of the present application.
[0030] The enzyme-labeled antibody diluent provided in the present application significantly improves the stability of the enzyme-labeled antibody, and the ELISA test kit containing the enzyme-labeled antibody diluent has better accuracy and stability. At the same time, the enzyme-labeled antibody diluent in the ELISA test kit can be provided separately, or the enzyme-labeled antibody can be directly diluted and provided as a diluted enzyme-labeled antibody solution. Since the enzyme-labeled antibody needs to be stored at -20°C to have a longer shelf life, and the storage condition of the components in the ELISA kit is 2-8°C, the diluted enzyme-labeled antibody cannot be stored for a long time, and must be prepared and used immediately, which is extremely inconvenient to use. The enzyme-labeled antibody diluent provided in the present application has good stability for the enzyme-labeled antibody, so the enzyme-labeled antibody diluted with the diluent can also be stored at 2-8°C together with the ELISA kit, without the need for preparation and use, which is more convenient to use and effectively extends the shelf life of the kit.
[0031] The beneficial technical effect of the present application is that the components in the enzyme-labeled antibody diluent provided by the present application cooperate with each other, significantly improving the stability of the enzyme-labeled antibody, so that the ELISA detection kit containing the enzyme-labeled antibody diluent has better accuracy and stability. At the same time, the enzyme-labeled antibody diluent can dilute the enzyme-labeled antibody to a working concentration before the product leaves the factory, and can be stored at 2 to 8°C together with the ELISA kit, without the need for fresh preparation and use, making it more convenient to use, and effectively extending the shelf life of the kit, with good application prospects. BRIEF DESCRIPTION OF THE DRAWINGS
[0032] Figure 1 This is an example diagram of the microplate sample loading position in Test Example 1. DETAILED DESCRIPTION
[0033] In order to make the present application easier to understand, the present application will be further described in detail below in conjunction with the examples, which are merely illustrative and are not intended to limit the scope of application of the present application. The raw materials or components used in the present application can be obtained through commercial routes or conventional methods unless otherwise specified.
[0034] Example 1: Preparation of enzyme-labeled antibody diluent Composition: In terms of mass concentration, the components of the enzyme-labeled antibody diluent are as follows: 0.5% bovine serum albumin, 0.5% polyvinylpyrrolidone 40 (PVP40), 4 mM FeSO4, 0.1% corn thioredoxin and 0.05% Proclin300.
[0035] Preparation: Calculate the mass of each component according to the volume of 500 mL of enzyme-labeled antibody diluent and the concentration of the above components, weigh each component, add purified water, stir to dissolve, and finally make the volume to 500 mL, filter and sterilize with a 0.22 μm filter membrane to obtain enzyme-labeled antibody diluent.
[0036] Example 2: Preparation of enzyme-labeled antibody diluent Composition: basically the same as Example 1, except that the concentration of PVP40 in the enzyme-labeled antibody diluent is 0.1%.
[0037] Preparation: Same as Example 1.
[0038] Example 3: Preparation of enzyme-labeled antibody diluent Composition: basically the same as Example 1, except that the concentration of PVP40 in the enzyme-labeled antibody diluent is 1.0%.
[0039] Preparation: Same as Example 1.
[0040] Example 4: Preparation of enzyme-labeled antibody diluent Composition: basically the same as Example 1, except that the polyvinyl pyrrolidone in the enzyme-labeled antibody diluent is polyvinyl pyrrolidone K90.
[0041] Preparation: Same as Example 1.
[0042] Example 5: Preparation of enzyme-labeled antibody diluent Composition: basically the same as Example 1, except that the concentration of FeSO4 in the enzyme-labeled antibody diluent is 1 mM.
[0043] Preparation: Same as Example 1.
[0044] Example 6: Preparation of enzyme-labeled antibody diluent Composition: basically the same as Example 1, except that the concentration of FeSO4 in the enzyme-labeled antibody diluent is 8mM.
[0045] Preparation: Same as Example 1.
[0046] Example 7: Preparation of enzyme-labeled antibody diluent Composition: basically the same as Example 1, except that the mass concentration of corn thioredoxin in the enzyme-labeled antibody diluent is 0.02%.
[0047] Preparation: Same as Example 1.
[0048] Example 8: Preparation of enzyme-labeled antibody diluent Composition: basically the same as Example 1, except that the mass concentration of corn thioredoxin in the enzyme-labeled antibody diluent is 0.15%.
[0049] Preparation: Same as Example 1.
[0050] Example 9: Preparation of enzyme-labeled antibody diluent Composition: basically the same as Example 1, except that the enzyme-labeled antibody diluent also includes lysine with a mass concentration of 2%, wherein the mass ratio of lysine to bovine serum albumin is 4:1.
[0051] Preparation: Same as Example 1.
[0052] Example 10: Preparation of enzyme-labeled antibody diluent Composition: basically the same as Example 1, except that the enzyme-labeled antibody diluent also includes lysine with a mass concentration of 3%, wherein the mass ratio of lysine to bovine serum albumin is 6:1.
[0053] Preparation: Same as Example 1.
[0054] Example 11: Preparation of enzyme-labeled antibody diluent Composition: basically the same as Example 10, except that the mass concentration of bovine serum albumin in the enzyme-labeled antibody diluent is 0.75%, wherein the mass ratio of lysine to bovine serum albumin is 4:1.
[0055] Preparation: Same as Example 1.
[0056] Example 12: Preparation of enzyme-labeled antibody diluent Composition: basically the same as Example 9, except that the enzyme-labeled antibody diluent also includes histidine with a mass concentration of 0.05%, wherein the mass ratio of histidine to corn thioredoxin is 0.5:1.
[0057] Preparation: Same as Example 1.
[0058] Example 13: Preparation of enzyme-labeled antibody diluent Composition: basically the same as Example 9, except that the enzyme-labeled antibody diluent also includes histidine with a mass concentration of 0.1%, wherein the mass ratio of histidine to corn thioredoxin is 1:1.
[0059] Preparation: Same as Example 1.
[0060] Comparative Example 1: Preparation of enzyme-labeled antibody diluent Composition: basically the same as Example 1, except that the medium-quality polyvinyl pyrrolidone 40 in the enzyme-labeled antibody diluent is replaced by FeSO4.
[0061] Preparation: Same as Example 1.
[0062] Comparative Example 2: Preparation of enzyme-labeled antibody diluent Composition: basically the same as Example 1, except that the medium-quality FeSO4 in the enzyme-labeled antibody diluent is replaced by polyvinyl pyrrolidone 40.
[0063] Preparation: Same as Example 1.
[0064] Comparative Example 3: Preparation of enzyme-labeled antibody diluent Composition: basically the same as Example 9, except that the enzyme-labeled antibody diluent does not contain bovine serum albumin, and the mass concentration of lysine is 2.5%.
[0065] Preparation: Same as Example 1.
[0066] Comparative Example 4: Preparation of enzyme-labeled antibody diluent Composition: basically the same as Example 12, except that the enzyme-labeled antibody diluent does not contain corn thioredoxin, and the mass concentration of histidine is 0.15%.
[0067] Preparation: Same as Example 1.
[0068] Test Example 1: Stability Test
[0069] 1. Detection method
[0070] The stability test was carried out using the African swine fever virus ELISA antibody test kit produced by Beijing Jinnuo Biotech Co., Ltd. The test steps are as follows:
[0071] (1) Take out all components from the kit and place them in a constant temperature box (25℃±3℃) for at least 60 minutes.
[0072] (2) Dilute the sample 50 times. Figure 1 ), add 245 μL of sample diluent to each well of the dilution plate, add 5 μL of sample to each well, and mix thoroughly.
[0073] (3) According to the “Microplate Sample Loading Position Example Diagram”, add 100 μL of the sample diluted in advance in the dilution plate to the designated wells of the antigen-coated plate.
[0074] (4) Add 100 μL of undiluted negative control serum (NC) and positive control serum (PC) to the designated wells.
[0075] (5) Cover with sealing film and incubate in a constant temperature box (25℃±3℃) for 30 minutes (±1 minute).
[0076] (6) Wash the plate using ELISA
[0077] Wash the plate with a micropipette or a micro-pipette, discard the liquid in the wells, add 300 μL of 1x washing solution to each well, and wash 3 times. After the last wash, gently pat the ELISA plate dry on absorbent paper. It is strictly forbidden to dry the wells between steps.
[0078] (7) Add 100 μL of ASFV enzyme-labeled antibody working solution (working concentration) prepared by diluting with enzyme-labeled diluent to each well. Warning: Do not reuse the HRP marker that has been poured out of the bottle.
[0079] (8) Cover with sealing film and incubate in a constant temperature box (25℃±3℃) for 30 minutes (±1 minute).
[0080] (9) Repeat step (6).
[0081] (10) Add 100 μL of TMB substrate solution to each well.
[0082] (11) Cover with sealing film and incubate in a constant temperature incubator (25℃±3℃) for 15 minutes (±1 minute).
[0083] (12) Add 50 μL of stop solution to each well to terminate the enzymatic reaction.
[0084] (13) Measure the absorbance (OD value) at a wavelength of 450 nm.
[0085] (14) Result determination and calculation.
[0086] determination:
[0087] (1) Test establishment conditions
[0088] Positive control OD 450nm Average value > 0.8;
[0089] Negative control OD 450nm Average value < 0.2;
[0090] If the test result is not within the defined range, retesting is required.
[0091] (2) Calculation method
[0092]
[0093]
[0094] (3) Sample S / P value calculation formula
[0095]
[0096] 1. Criteria
[0097] Positive suspicious Negative S / P≥0.4 0.4>S / P>0.3 S / P≤0.3
[0098] For samples with suspicious test results, it is recommended to test them again.
[0099] 2. Stability test
[0100] The ASFV enzyme-labeled antibody was diluted with the enzyme-labeled antibody diluents prepared in Examples 1-13 and Comparative Examples 1-4 to prepare ASFV enzyme-labeled antibody working solutions. Then, the same sample was tested using ASFV enzyme-labeled antibody working solutions prepared with different enzyme-labeled antibody diluents and a matching kit to obtain the sample OD value (reference value) after detection with different enzyme-labeled antibody diluents. The remaining ASFV enzyme-labeled antibody working solutions prepared with different enzyme-labeled antibody diluents after detection were placed in a dry condition at 4°C for storage, taken out for detection every 2 months, and sampled until the 22nd month, and the rate of decrease of the sample OD value after storage compared to the respective reference values was calculated, and the test results are shown in Table 1. The detection process repeated the detection of the same sample 5 times, and the test results were averaged. The calculation formula for the rate of decrease is: (reference value-sample OD value after storage) / reference value x100%.
[0101] Table 1: Effect of different enzyme-labeled antibody diluents on the sample OD value decrease rate (%)
[0102]
[0103]
[0104] From the test results in Table 1, it can be seen that compared with the enzyme-labeled antibody diluent prepared in Comparative Examples 1-4, the enzyme-labeled antibody diluent prepared in Examples 1-13 of the present application significantly improves the stability of the enzyme-labeled antibody. The ASFV enzyme-labeled antibody working solution prepared by the enzyme-labeled antibody diluent in Examples 1-13 has no significant decrease in the OD value of the sample detection after 22 months of storage, and the OD value decrease rate is only about 6% at most. The ASFV enzyme-labeled antibody working solution prepared by the enzyme-labeled antibody diluent in Comparative Examples 1-4 has significantly decreased the OD value of the sample detection after 4 months of storage, and the CV value of the test result increases accordingly, and the detection performance decreases significantly. It can be seen that the ELISA test kit containing the enzyme-labeled antibody diluent provided in this application has better accuracy and stability. At the same time, since the ASFV enzyme-labeled antibody working solution prepared by the enzyme-labeled antibody diluent can be stored at 2 to 8 ° C for at least 22 months, the enzyme-labeled antibody diluent can dilute the enzyme-labeled antibody to the working concentration before the product leaves the factory, without the need for ready-to-use, and is more convenient to use, and effectively extends the shelf life of the test kit.
[0105] From the test results of Examples 1-4, it can be seen that when the polyvinyl pyrrolidone in the enzyme-labeled antibody diluent is PVP40 and its mass concentration is controlled at 0.4-0.6%, especially 0.5%, the stability of the enzyme-labeled antibody can be better. From the test results of Examples 1 and 5-6, it can be seen that when the concentration of FeSO4 in the enzyme-labeled antibody diluent is controlled at 3-5mM, especially at 4mM, the stability of the enzyme-labeled antibody can be better. From the test results of Example 1 and Comparative Examples 1-2, it can be seen that polyvinyl pyrrolidone and FeSO4 in the enzyme-labeled antibody diluent have a synergistic effect. Through the synergistic effect of the two, the antibody titer and the activity of the stabilized enzyme can be better protected, thereby improving the stability of the kit.
[0106] From the test results of Examples 1 and 7-8, it can be seen that when the mass concentration of thioredoxin in the enzyme-labeled diluent is controlled at 0.08-0.12%, especially at 0.1, the enzyme-labeled antibody can have better stability. From the test results of Examples 1 and 9-11, it can be seen that when lysine is further added to the enzyme-labeled diluent, it helps to improve the stability of the enzyme-labeled antibody, and when the mass ratio of lysine to bovine serum albumin is 4:1, the enzyme-labeled antibody can have better stability. From the test results of Examples 9 and 12-13, it can be seen that when histidine is further added to the enzyme-labeled diluent, it helps to improve the stability of the enzyme-labeled antibody, and when the mass ratio of histidine to thioredoxin is 0.5:1, the enzyme-labeled antibody can have better stability.
[0107] It should be noted that the embodiments described above are only used to explain the present application and do not constitute any limitation to the present application. The present application is described with reference to typical embodiments, but it should be understood that the words used therein are descriptive and explanatory words, rather than restrictive words. The present application may be modified as specified within the scope of the claims of the present application, and the present invention may be revised without departing from the scope and spirit of the present application. Although the present application described therein relates to specific methods, materials and embodiments, it does not mean that the present application is limited to the specific examples disclosed therein. On the contrary, the present application can be extended to all other methods and applications with the same functions.
Claims
1. A horseradish peroxidase-labeled antibody diluent for an ELISA test kit, characterized in that: In terms of mass concentration, the components of the horseradish peroxidase-labeled antibody dilution solution are: 0.75-1.0% bovine serum albumin, 0.4-0.6% polyvinyl pyrrolidone 40, 3-5 mM FeSO4, 0.08-0.12% thioredoxin, 0.01-0.1% preservative, 1-3% lysine in a mass ratio of lysine to bovine serum albumin of (3-5):1, and histidine in a mass ratio of 0.5:1 to thioredoxin; The preservative is selected from at least one of Proclin 150, Proclin 300 and Proclin 950.
2. A method for preparing the horseradish peroxidase-labeled antibody dilution according to claim 1, characterized in that: The method comprises: mixing the components in the horseradish peroxidase labeled antibody diluent with water, filtering and sterilizing, and obtaining the horseradish peroxidase labeled antibody diluent.
3. An ELISA detection kit, comprising the horseradish peroxidase-labeled antibody diluent as claimed in claim 1, or comprising an enzyme-labeled antibody solution diluted with the horseradish peroxidase-labeled antibody diluent as claimed in claim 1.
Citation Information
Patent Citations
Stable protein solution, preparation method thereof and detection kit
CN111024959A
Compound enzyme solution, alcohol detection test paper, and preparation method and application of alcohol detection test paper
CN112034022A
Stabilizer for ELISA kit coated plate, preparation method of stabilizer, kit coated plate and kit
CN113267621A
Preserving method for liquid diagnostic medicament
CN1156113A
Detection kit for triple detection of cat virus antibody
CN115993445A
